- 询价
- Nebulabio
- 中国
- NBL-291255
- 2026年01月04日
企业认证
相关产品推荐更多 >
Carcinoembryonic Antigen Related Cell Adhesion Molecule 1 (CEACAM1), 35-321aa, His-tag
询价
Transthyretin (TTR）蛋白 | Transthyretin（TTR）, 21-147aa, His-tag, SUMO-tag
询价
Fibronectin Fragment 2蛋白 | Human Fibronectin Fragment 2 Protein
询价
重组人KIF23蛋白 | Recombinant Human KIF23 Protein, 22-458aa, His-tag
询价PCNA蛋白 | Human PCNA Protein
询价
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 保质期：
见COA
- 库存：
大量
- 供应商：
北京辰辉创聚生物技术有限公司
- 规格：
100ug; 500ug; 1mg; Bulk
| 产品信息
品名：NebuSelect™ Recombinant Human CD68 Protein
中文名称：重组人CD68蛋白
别名：CD68, Gp110, Macrosialin
货号：NBL-291255
品牌：Nebulabio
规格：100UG；1MG；Bulk
| 产品描述
NebuSelect™ Recombinant Human CD68 Protein (Cat# NBL-291255) is expressed in HEK293 cells with His tag. This recombinant protein is of high purity, verified to be greater than 90% by SDS-PAGE. Endotoxin levels are less than 1 EU/µg, as determined by the LAL (Limulus Amebocyte Lysate) assay.
| 产品属性
Species:Human
Expression System:HEK293 cells
Molecular Weight:8.4 kDa
Target Name:CD68
Purity:>90% by SDS-PAGE.
Formulation:See COA
Endotoxin:＜1 EU/ug(LAL Method)
Storage:4°C for short term. -20°C for long term.
For Research Use Only!
To get more information, please contact us freely.
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验Methods for Producing Recombinant Human Cellular Retinaldehyde-Binding Protein
The cellular retinaldehyde-binding protein (CRALBP) is expressed at high levels in vertebrate visual trssue, where it may serve to modulate the interaction of 11-cis -retinol with visual-cycle enzymes in the retinal pigment epithelium (RPE
Recombinant Protein Production in Yeasts
Recombinant protein production is a multibillion-dollar market. The development of a new product begins with the choice of a production host. While one single perfect host for every protein does not exist, several expression systems ranging
Recombinant Protein Expression in Nicotiana
Recombinant protein pharmaceuticals are now widely used in treatment of chronic diseases, and several recombinant protein subunit vaccines are approved for human and veterinary use. With growing demand for complex protein pharmaceuticals
技术资料暂无技术资料 索取技术资料
